Sandra Springer, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Gilead Sciences
    Topic:
    CJS
    Date added:
    10/15/2026
    Date updated:
    10/15/2026
    Relationship end date:
    11/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Eli Lilly
    Topic:
    GLP1 RA tx of OUD and Tobacco Use Disorder Data Safety Monitoring board member
    Date added:
    10/15/2026
    Date updated:
    10/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Indivior
    Topic:
    in kind study drug donations for NIH and VA sponsored reserach
    Date added:
    10/15/2026
    Date updated:
    10/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Braeburn
    Topic:
    in kin study drug donation for NIH sponsored research
    Date added:
    10/15/2026
    Date updated:
    10/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Alkermes Inc
    Topic:
    In kind study drug donation for NIH sponsored research
    Date added:
    10/15/2026
    Date updated:
    10/15/2026
    Relationship end date:
    01/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Cepheid
    Topic:
    in kind study HCV viral load machine donation for NIH sponsored research
    Date added:
    10/15/2026
    Date updated:
    10/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Roche
    Topic:
    grant funding for STI testing with NIH sponsored research
    Date added:
    10/15/2026
    Date updated:
    10/15/2026
Return to HIV & SUD Virtual Symposium